Correlation Between GlaxoSmithKline PLC and Telecomunicaes Brasileiras
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Telecomunicaes Brasileiras at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Telecomunicaes Brasileiras into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Telecomunicaes Brasileiras SA, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Telecomunicaes Brasileiras and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Telecomunicaes Brasileiras. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Telecomunicaes Brasileiras.
Diversification Opportunities for GlaxoSmithKline PLC and Telecomunicaes Brasileiras
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between GlaxoSmithKline and Telecomunicaes is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Telecomunicaes Brasileiras SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telecomunicaes Brasileiras and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Telecomunicaes Brasileiras. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telecomunicaes Brasileiras has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Telecomunicaes Brasileiras go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Telecomunicaes Brasileiras
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to generate 0.56 times more return on investment than Telecomunicaes Brasileiras. However, GlaxoSmithKline PLC ADR is 1.77 times less risky than Telecomunicaes Brasileiras. It trades about -0.31 of its potential returns per unit of risk. Telecomunicaes Brasileiras SA is currently generating about -0.2 per unit of risk. If you would invest 3,745 in GlaxoSmithKline PLC ADR on August 28, 2024 and sell it today you would lose (343.00) from holding GlaxoSmithKline PLC ADR or give up 9.16% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 90.91% |
Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Telecomunicaes Brasileiras SA
Performance |
Timeline |
GlaxoSmithKline PLC ADR |
Telecomunicaes Brasileiras |
GlaxoSmithKline PLC and Telecomunicaes Brasileiras Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with GlaxoSmithKline PLC and Telecomunicaes Brasileiras
The main advantage of trading using opposite GlaxoSmithKline PLC and Telecomunicaes Brasileiras positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Telecomunicaes Brasileiras can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telecomunicaes Brasileiras will offset losses from the drop in Telecomunicaes Brasileiras' long position.GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |